Clinical Trial Update: Functional Assessment of Patients With Acute Bipolar Depression After 8 Months of Follow-up

View source ↗

Summary

The update provides functional outcome data from AstraZeneca's trial in patients with acute bipolar depression after 8 months of follow-up.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Depression
• Bipolar Disorder

Snippet

Sponsor: AstraZeneca | Conditions: Bipolar Disorder, Bipolar Depression | Status: COMPLETED